If the new messenger RNA technology powering the Pfizer and Moderna COVID-19 vaccines is giving you pause about getting the shot, consider this:
As you read this editorial, mRNA is at work within your body's cells and has been before you even took your first breath. At the most basic, mRNA acts as a short-lived shuttle, ferrying the instructions for making proteins to the cellular structures that produce them. In turn, these proteins fuel the chemical reactions that metabolize our food and create bone and muscle, among other vital processes.
"One of the important worker bees of the body" is how the University of Minnesota's Marc Jenkins, director of the Center for Immunology, sums up mRNA's practical ongoing importance.
The Pfizer and Moderna vaccines may be a new type of vaccine, but as the nation struggles with COVID vaccine hesitancy, it's important to note that these shots work by leveraging the naturally occurring blueprint-for-building-proteins process described above. Essentially, these two vaccines provide another protein recipe, one that the body doesn't make, to prime the immune system to recognize and fight off the COVID virus.
Lack of understanding about mRNA and how it works has regrettably led to misunderstandings and outright falsehoods — chief among them, that mRNA vaccines are "gene therapy" — about the Pfizer and Moderna vaccines. That's problematic when the pair has become the workhorses of the COVID vaccination campaign and widespread vaccination is needed to stamp out viral spread.
As of Friday, 54.1% of Minnesotans ages 12 and up are fully vaccinated. Pfizer constitutes 55% of vaccine doses administered in the state, and it's currently the only vaccine authorized for use in those ages 12-15.
Moderna comprises 40.5% of doses administered here. Production problems and a temporary pause to study a rare side effect have stymied wider use of the Johnson & Johnson vaccine, which relies on an older method of stimulating an immune response.
Because of the Pfizer and Moderna vaccines' important role in ending the pandemic, the Star Tribune Editorial Board enlisted Jenkins to address concerns about them as part of its ongoing "Our Best Shot" series tackling vaccine hesitancy. Jenkins is also professor at the U's medical school and in 2020 was elected to the National Academy of Sciences, a high honor reserved for those with "distinguished and continuing achievements in original research."